Neurobiological Technologies Inc. (NTII)
OTC PINK OTC PINK Primary Summary
Neurobiological Technologies Inc. (NTII) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Neurobiological Technologies Inc. ever had a stock split?
Neurobiological Technologies Inc. Profile
| Biotechnology Industry | Healthcare Sector | John B. Stuppin CEO | OTC PINK Exchange | 64124W304 CUSIP |
| US Country | 4 Employees | 27 Dec 2012 Last Dividend | 17 Sep 2007 Last Split | 16 Feb 1994 IPO Date |
Overview
Neurobiological Technologies, Inc. was a biopharmaceutical company based in Emeryville, California, with a significant focus on developing investigational drugs aimed at treating human diseases. Since its establishment in 1987, the company dedicated itself to the identification, development, and commercialization of new therapies until its shareholders approved a plan for liquidation and dissolution in October 2009. This decision marked the end of the company's operational journey and its transition into the process of winding down its affairs.
Products and Services
Before its dissolution, Neurobiological Technologies, Inc. was involved in the development of several investigational drugs aimed at addressing various neurological conditions. Though the company has ceased its operations, the following were its notable areas of focus:
- Investigational Drugs for Neurological Disorders: The core mission was to develop new therapeutic options for neurological conditions, leveraging innovative research and development strategies to bring these medications from the lab to clinical trials.
- Treatment of Human Diseases: Beyond neurological disorders, the company aimed at broader therapeutic areas, contributing to the research and development of drugs with the potential to treat a wide range of human diseases.
